Related Experiment Video
Updated: Feb 21, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.8K
Migraine Treatment in Pregnancy and Lactation
1Carolina Headache Institute, Durham, NC, USA. CalhounA@chi09.com.
Current Pain and Headache Reports
|October 6, 2017
Summary
Migraine treatment during pregnancy and lactation lacks sufficient research and clear guidelines. More studies are urgently needed to ensure safe and effective options for expectant and nursing mothers.
Area of Science:
- Neurology
- Obstetrics
- Pharmacology
Background:
- Migraine affects a significant percentage of reproductive-aged women, many of whom become pregnant.
- There is a critical need for evidence-based guidelines for managing migraine during pregnancy and lactation.
Purpose of the Study:
- To review current risk and safety information for migraine pharmacotherapy during pregnancy and lactation.
- To highlight the paucity of recent research in this crucial area of women's health.
Main Methods:
- Comprehensive literature review of publications on migraine treatment in pregnancy and lactation.
- Analysis of existing data on drug safety and efficacy, incorporating both recent and older studies.
Main Results:
- A significant lack of formal research on migraine pharmacotherapy during pregnancy and lactation was identified.
- Limited new publications address the treatment of migraine in these sensitive periods.
- Concerns regarding physician training in hormonal influences and potential litigation contribute to research scarcity.
Conclusions:
- There is an urgent need for increased research into safe and effective migraine treatments for pregnant and lactating women.
- Current guidelines are insufficient due to a lack of robust scientific evidence.
- Addressing knowledge gaps and mitigating concerns are essential for improving patient care.
Related Concept Videos
01:19Mitral Valve Prolapse III: Nursing Management
447
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
447
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
1.2K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
1.2K
01:24Mania and Antimanic Drugs: Overview
677
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
677
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
726
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
726
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.3K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.3K
01:21Drugs for Treatment of Constipation-Predominant IBS
943
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
943